Director, Medical Communications
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
As a new member of the Revolution Medicines team, the Director, Medical Communications will lead the development and execution of a comprehensive medical communications strategy, ensuring alignment across internal and external stakeholders for select assets across pipeline, with focus on pancreatic cancer, NSCLC, colorectal cancer, and other solid tumors.
This role will oversee scientific communications platforms, publication strategies and operations and contribute to medical content supporting the
